₹ 5.7 Cr
Volume transacted
62.5 K
stocks traded
Last Updated time: 18 Sep 9.00 AM
Shilpa Medicare Ltd
NSE: SHILPAMED
ISIN
INE790G01031
Last updated: 18 Sep 9.00 AM
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Shilpa Medicare Ltd
NSE: SHILPAMED
PRICE
₹ 904.6
12.80 (1.44%)
Last updated: 18 Sep 15:30
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
18 Sep 2024 | 904.6 | 890.85 | 959.95 | 883.65 |
17 Sep 2024 | 891.8 | 885.1 | 898.05 | 875 |
16 Sep 2024 | 894.4 | 905 | 922 | 884.95 |
13 Sep 2024 | 883.05 | 890 | 919.95 | 870.4 |
12 Sep 2024 | 892.6 | 892.5 | 908.75 | 880.05 |
11 Sep 2024 | 877.5 | 854.7 | 903.7 | 836.05 |
10 Sep 2024 | 843.45 | 832.5 | 855.75 | 830.6 |
09 Sep 2024 | 831.9 | 824.85 | 846.95 | 815.05 |
06 Sep 2024 | 808.65 | 845.95 | 845.95 | 797 |
05 Sep 2024 | 829.35 | 813.85 | 853.75 | 807.65 |
Date | Price |
---|---|
18 Sep 2024 | 904.6 |
17 Sep 2024 | 891.8 |
16 Sep 2024 | 894.4 |
13 Sep 2024 | 883.05 |
12 Sep 2024 | 892.6 |
11 Sep 2024 | 877.5 |
10 Sep 2024 | 843.45 |
09 Sep 2024 | 831.9 |
06 Sep 2024 | 808.65 |
05 Sep 2024 | 829.35 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01023 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Dr Reddys Laboratories Ltd | INE089A01023 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Last updated time: 18 Sep 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Shilpa Medicare Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Shilpa Medicare Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA fo...
Read more
04 Sep 202415:14
Shilpa Medicare hits life high on submission of new drug application to USFDA
The said drug is used for treatment of hyperphosphatemia in patients with chronic kidney d...
Read more
04 Sep 202415:24
Shilpa Medicare hits record high on USFDA nod for cancer drug
The said product is the first liquid injection for Bortezomib, approved for both subcutane...
Read more
27 Aug 202414:43
Shilpa Medicare successfully completes phase-3 clinical studies of NorUDCA
Shilpa Medicare has successfully completed phase-3 clinical studies of its novel product S...
Read more
26 Aug 202410:30
Shilpa Medicare hits 52-week high on successful trial of fatty liver drug
NorUDCA is expected to revolutionise the treatment of patients suffering from Nonalcoholic...
Read more
26 Aug 202412:41
Shilpa Medicare to conduct AGM
Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will b...
Read more
16 Aug 202410:54
FAQs for ISIN of Shilpa Medicare Ltd
What is the ISIN code for Shilpa Medicare Ltd?
Why is Shilpa Medicare Ltd ISIN code important?
Can the ISIN code for Shilpa Medicare Ltd change?
Can I use the ISIN code for trading Shilpa Medicare Ltd shares?
How can I verify the ISIN code for Shilpa Medicare Ltd?
What happens if Shilpa Medicare Ltd issues new securities?
Unlimited trading at just
Rs. 199*